Innophos Holdings Inc (NASDAQ:IPHS) 2016 Q4 Institutional Investor Sentiment Steady

July 18, 2017 - By Darrin Black

 Innophos Holdings Inc (NASDAQ:IPHS)  2016 Q4 Institutional Investor Sentiment Steady

Sentiment for Innophos Holdings Inc (NASDAQ:IPHS)

Innophos Holdings Inc (NASDAQ:IPHS) institutional sentiment decreased to 1.06 in 2016 Q4. Its down -0.24, from 1.3 in 2016Q3. The ratio dropped, as 88 active investment managers started new and increased positions, while 83 sold and trimmed holdings in Innophos Holdings Inc. The active investment managers in our partner’s database now possess: 17.78 million shares, up from 17.78 million shares in 2016Q3. Also, the number of active investment managers holding Innophos Holdings Inc in their top 10 positions was flat from 0 to 0 for the same number . Sold All: 14 Reduced: 69 Increased: 54 New Position: 34.

Innophos Holdings, Inc. is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The company has market cap of $836.89 million. The Firm also provides bioactive mineral and nutritional ingredients. It has a 18.45 P/E ratio. The Company’s divisions include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and Granular Triple Super Phosphate & Other.

It closed at $42.97 lastly. It is down 18.50% since July 18, 2016 and is uptrending. It has outperformed by 1.80% the S&P500.

Wall Street await Innophos Holdings, Inc. (NASDAQ:IPHS) to release earnings on August, 7. Analysts forecast earnings per share of $0.66, up exactly $0.05 or 8.20 % from 2014’s $0.61 EPS. The expected IPHS’s profit could reach $12.85 million giving the stock 16.28 P/E in the case that $0.66 earnings per share is reported. After posting $0.59 EPS for the previous quarter, Innophos Holdings, Inc.’s analysts now forecast 11.86 % EPS growth.

Kestrel Investment Management Corp holds 2.39% of its portfolio in Innophos Holdings, Inc. for 122,400 shares. Daruma Capital Management Llc owns 693,169 shares or 2.06% of their US portfolio. Moreover, Ironwood Investment Management Llc has 1.35% invested in the company for 35,425 shares. The Maryland-based Investment Counselors Of Maryland Llc has invested 1.02% in the stock. Heartland Advisors Inc, a Wisconsin-based fund reported 288,836 shares.#img1#

Since January 1, 0001, it had 0 insider purchases, and 1 sale for $676,272 activity.

Innophos Holdings, Inc. (NASDAQ:IPHS) Ratings Coverage

Ratings analysis reveals 50% of Innophos Holdings’s analysts are positive. Out of 2 Wall Street analysts rating Innophos Holdings, 1 give it “Buy”, 1 “Sell” rating, while 0 recommend “Hold”. IPHS was included in 5 notes of analysts from August 24, 2015. On Monday, August 24 the stock rating was upgraded by Zacks to “Sell”. The stock of Innophos Holdings, Inc. (NASDAQ:IPHS) has “Neutral” rating given on Friday, December 16 by Sidoti. Zacks downgraded the shares of IPHS in report on Thursday, September 3 to “Sell” rating. The firm earned “Buy” rating on Thursday, October 20 by Sidoti. The firm has “Buy” rating given on Friday, May 26 by Sidoti.

More notable recent Innophos Holdings, Inc. (NASDAQ:IPHS) news were published by: which released: “Sharon Merrill Associates Announces the Addition of Innophos Holdings Inc. to …” on June 06, 2017, also with their article: “Innophos Secures Long-Term Viability of Geismar Phosphoric Acid Facility” published on January 12, 2017, published: “Innophos Unveils “Vision 2022: The Path to Revitalized Growth” Targeting $1.25 …” on April 05, 2017. More interesting news about Innophos Holdings, Inc. (NASDAQ:IPHS) were released by: and their article: “Innophos Holdings, Inc. Appoints Seasoned Global Operations Executive Mark …” published on April 27, 2017 as well as‘s news article titled: “Innophos To Host First Quarter 2017 Financial Results Conference Call On May 2” with publication date: April 18, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: